Skip to main content
Equibles

Jefferies Financial Group Inc.

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 96223 NEW YORK, NY
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$2,239,128
+$97,998 QoQ
Shares Held
328,800
-31.4% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#69
of 208 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names. TSHA ranks #33 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PTCT
Ptc Therapeutics, Inc.
 1,357,042 $110,693,915
2 URGN
UroGen Pharma Ltd.
 2,199,652 $80,947,193
3 IMTX
Immatics N.V.
 6,506,802 $65,913,904
4 TNGX
Tango Therapeutics, Inc.
 2,010,534 $62,849,292
5 CGON
CG Oncology, Inc.
 769,947 $54,704,734
6 ARGX
Argenx SE
 45,068 $41,812,738
7 RARE
Ultragenyx Pharmaceutical Inc.
 929,626 $31,040,212
8 BMRN
Biomarin Pharmaceutical Inc
 466,258 $26,679,282

All Filings in TSHA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,239,128 328,800
2026-03-31 $2,141,130 479,000
2025-12-31 $137,500 25,000
2025-09-30 $7,052,219 2,156,642
2025-06-30 $23,824,723 10,313,733
2025-03-31 $340,903 245,254
2024-09-30 $148,452 73,857
2024-06-30 $577,234 257,694
2024-03-31 $138,047 48,100